The Journal of International Drug Policy is reporting that circumstantial evidence from a variety of models show that using a newly developed syringe that reduces dead space by a thousand percent from current syringes has high probablity that HIV, Hepatitis C and other blood borne diseases could be reduced to zero within 8 years.